Come stop by to see CPP as we will be exhibiting at the AAP National Conference & Exhibition, alongside Nationwide Children’s Hospital (booth # 2217) in the exhibit hall during the conference!
Related Posts
Stop by to see CPP as we will be exhibiting at the AAP National Conference & Exhibition September 27th-October 1st,…
It’s time for your annual vaccine management check-up! This tool is designed to help you check up on the financial…
Dynavax is hosting a live webinar series on July 25th and 26th 2023 discussing hepatitis B vaccination in support of World Hepatitis Day, which is…
Vaccine Updates – Pfizer Recently, Pfizer communicated some changes to their vaccine portfolio. The addition of Pfizer’s Penbraya™, a new pentavalent…
The first of the year is usually when vaccine manufacturers increase their prices therefore, it is important that practices evaluate…
Great News! CPP has renewed our partnership with GoCheck Kids, a leading pediatric vision screening platform that aligns with the AAP recommendations…
Vaccine uncertainty has led to more individuals questioning vaccines and delaying or refusing vaccines as the pandemic has increased uncertainty…
CPP members don’t forget that Friday, April,19th, is the last day to pre-book Fluzone®, High-Dose Fluzone and Flublok® vaccines for…
August is National Immunization Awareness Month (NIAM), a time to spread the word and highlight the importance of vaccines in…
Vaccines are a cornerstone of public health, requiring proper storage and handling. In emergencies whether due to natural disasters, power…
As winter storms sweep through different parts of the country, maintaining the integrity of vaccines becomes a critical concern for…
The Centers for Disease Control and Prevention (CDC) has released the 2025 immunization schedules for child & adolescent and adults. Below…
Measles is on the rise across the world and country. As flu, COVID and RSV continue to be a concern,…
CPP will be attending and exhibiting at the 2024 AMGA Annual Conference in sunny Orlando, FL April 9-12. Stop by…
RSV MONOCLONAL ANTIBODY (INFANTS) On August 3rd, the ACIP voted unanimously and recommended the use of Sanofi and AstraZeneca’s Beyfortus™,…